Enhancing mitochondrial biogenesis and function could potentially alleviate some of the neurodegenerative processes associated with tau mutations that contribute to synaptic impairment and cognitive decline in AD and FTD.12, 14, 47, 58. Here, MAPT is linked to Alzheimer disease.